OXiGENE, Inc. (OXGN) - NASDAQ
Company Description
Oxigene, Inc. is a biopharmaceutical company, which focus on the development of vascular disrupting agents, or VDAs, for the treatment of cancer. It products include VDAs-CA4P and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, CA.
Sector: Healthcare
Industry: Biotechnology
Country: United States